Cargando...
Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.
Gardado en:
| Publicado en: | Indian J Dermatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601460/ https://ncbi.nlm.nih.gov/pubmed/26538739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.164447 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|